Aurora cannabis inc. announces us$125 million bought deal financing

Edmonton, ab, may 26, 2022 /prnewswire/ - aurora cannabis inc. ("aurora" or the "company") (nasdaq: acb) (tsx: acb), the canadian company defining the future of cannabinoids worldwide, today has announced today that it has entered into an agreement with a syndicate of underwriters led by canaccord genuity and bmo capital markets, under which the underwriters have agreed to buy on bought deal basis 51.1 million units of the company (the "units"), at a price of us$2.45 per unit for gross proceeds of approximately us$125.2 million (the "offering"). each unit will be comprised of one common share of the company (a "common share") and one common share purchase warrant of the company (a "warrant").
ACB Ratings Summary
ACB Quant Ranking